X4 Pharmaceuticals

X4 Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare diseases of the immune system. Their lead product, mavorixafor, is a selective CXCR4 antagonist that has received U.S. approval for the treatment of WHIM syndrome and is currently being investigated for additional indications, including chronic neutropenic disorders. X4 Pharmaceuticals has a strong commitment to patient-centricity, reflected in their focus on improving access to treatment and their dedication to conducting clinical trials that benefit those with significant unmet needs.

X4 Pharmaceuticals operates with a core set of values that guide their work, including excellence, accountability, camaraderie, integrity, a sense of urgency, and grit. The company has a global presence with headquarters in Boston, Massachusetts and a research center of excellence in Vienna, Austria, where scientists are focused on new drug discovery, understanding the CXCR4 pathway, and exploring the genetic causes of certain immune disorders. Their commitment to research and development, coupled with their dedication to patients, positions X4 Pharmaceuticals as a leader in the field of rare disease therapies.

X4 Pharmaceuticals offers a hybrid work location benefit for full-time employees in the United States, allowing for a balance between office and remote work. While specific details about the arrangement are not explicitly mentioned, the inclusion of this benefit suggests a degree of flexibility in where and how employees can perform their work.

X4 Pharmaceuticals offers a comprehensive and competitive benefits package to its full-time employees, including health, dental, and life insurance, as well as disability coverage, a 401(k) plan with employer match, an employee stock purchase program, and competitive vacation, sick, and PTO benefits. They also provide 12 paid holidays, a year-end holiday shutdown, summer Fridays, parental leave, a hybrid work location benefit, free parking, a subsidized commuter benefit, an employee assistance program, and cell phone and internet reimbursement.

X4 Pharmaceuticals focuses on developing and commercializing innovative therapies for people with rare diseases of the immune system and significant unmet needs. They leverage their expertise in CXCR4 and immune system biology, with a specific focus on bringing innovative treatments to people with rare diseases of the immune system, specifically those with chronic neutropenia and WHIM syndrome. They are committed to upholding the highest standards of integrity and ethics in everything they do, and place the patient at the center of their mission.

X4 Pharmaceuticals fosters a culture of excellence, accountability, and camaraderie. They emphasize a strong work ethic with a sense of urgency to deliver innovative therapies for patients, prioritizing integrity and transparency in all their actions. They value teamwork and respect, ensuring open communication and collaboration amongst their employees, partners, and the medical community. Their commitment to career development ensures that each employee can reach their full potential.

X4 Pharmaceuticals is committed to fostering a diverse, equitable, and inclusive work environment. They emphasize open communication, collaboration, and respect for all employees. This commitment is evident in their core values, which include accountability, camaraderie, and integrity. X4 also offers a comprehensive and competitive benefits package, including employee assistance programs and parental leave, and promotes a culture of transparency and excellence for all employees.